The Future of Pharmaceutical Industry
Dear Nyenrode Alumni and VCV affiliates,
After the success of previous theme meetings of the VCV Healthcare, you are invited to participate in a discussion evening on The Future of Pharmaceutical Industry. This event will take place on Thursday, February 7, 2019. We start at 18:00 in the AH building of the Nyenrode Business University.
We would like to invite you to participate in the discussion on this theme in search of answers and further deepening. We are pleased that we can present two renowned speakers to you:
Marcel T.M. van Raaij PhD is since October 2014 the Director of Pharmaceutical Affairs and Medical Technology at the Ministry of Health in the Netherlands. The Directorate is responsible for the policy making on pharmaceuticals (from innovation, market access, safe use to pricing and reimbursement), medical devices and technology and tibessues and cells including organ donation policy. Marcel van Raaij studied Medical Biology at the State University of Leiden (The Netherlands) and received his PhD in Physiology at the same university.
After his PhD he moved to the National Institute of Public Health and Environment (RIVM). He worked in the toxicological risk assessment and was active in various international working groups and commissions (EU, WHO, OECD, US EPA). After leading the Center for Integrated Risk Assessment for a number of years at RIVM, he became acting director for Nutrition, Medicines and Consumer Safety. From 2011 to 2014 he was Director of Environment and Safety at RIVM dealing with environmental policy and physical safety including preparedness and response activities.
The Netherlands presented a new Pharma policy in January 2016 and proposed an active agenda on pharmaceutical policy during the Dutch Presidency of EU council in 2016. Since 2016 Marcel van Raaij is appointed as chairman of the Steering Committee of the BeNeLuxA initiative where The Netherlands, Belgium, Luxembourg, Austria and Ireland are working together on sustainable access to medicines in their countries.
Bert Hartog PhD is an experienced Senior Director and Innovation Leader. He leads transformational innovation projects that have the goal to shape the future of clinical trial execution, and position Janssen as a role model in patient-centered clinical research.
Bert is an industry expert in Global Clinical Operations and Digital Health. He graduated in Biomedicine and obtained a PhD in Medicine from Utrecht University. He worked in Clinical Operations, QA and IT management before joining Janssen’s Clinical Innovation team in 2015. His main focus today is developing capabilities for digital health in clinical trials, including digital outcome measures and technologies for remote patient monitoring.
18:00 -18:30 Registration and snacks
18:30 -18:35 Welcome by the board of the VCV Healthcare Circle
18:35 -19:00 Presentation “The Future of the Pharmaceutical Sector – Innovation and Business Models; a perspective from the public interest” – Marcel van Raaij
19:00 - 19:30 Interactive discussion with the speaker
19:30 - 19:45 Coffee break
19:45 - 20:10: Presentatie “Game Changing Capabilities For Clinical Research Leveraging Digital Technologies” – Bert Hartog
20:10 - 20:30 Interactive discussion with the speaker
20:30 - 21:00 Coffee break
21:00 Closure and network drinks in the Plesman Bar
We are looking forward to see you on Thursday 7th of February of 2019 in the AH building of Nyenrode.
Non members of the VCV are also welcome! They will need to register themselves by simply sending an e-mail to: email@example.com and wire the registration fee to: NL49INGB0003862745 t.n.v. M. Holling. Please include the following description “VCV Healthcare 7-2-2019”. You can also pay in cash on-site (only after registration by e-mail).
The board of the VCV Healthcare Circle
Qustions or suggestions? Please send us an e-mail: firstname.lastname@example.org